A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia
| Image |  |
|---|---|
| Description | scientific article published on 12 July 2016 |
| Author/s |
author: David Hedley Aaron Schimmer |
| Publication date | July 12, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |